Pharmapack 2024

Avery Dennison at Pharmapack 2024:

showcasing the latest technologies that boost patient safety

OEGSTGEEST, The Netherlands — 10 January 2024

Visit Avery Dennison at Pharmapack, Paris booth B98 24-25 January to discover how advanced label materials and RFID solutions are enabling unit-level traceability across the pharmaceutical supply chain – helping to boost patient safety, deliver unprecedented inventory accuracy and reduce waste.

Launched in 1997, Pharmapack is the leading European event for pharmaceutical packaging, drug delivery, medical devices, and machinery. At the event, Avery Dennison will outline the latest labeling solutions that enhance patient compliance, many of which feature digital identification technologies such as RFID (radio frequency identification) and NFC (near field communication) which are transforming the pharmaceutical industry.

Products tagged in this way can offer several advantages. For example, it can help reduce human error to prevent medication mix-ups, enable faster stock checks, and improve inventory management – reducing error rates to near zero. Attendees are invited to find out more at an Avery Dennison and Becton Dickinson hosted workshop entitled: ‘Transforming Pharma Fill/Finish Processes with RFID-enabled Pre-Fillable Syringes’ which takes place on January 24, 2024 at 14:30 to 15:10 CET at Pharmapack - Rooms 725 & 726.

Avery Dennison brings together unique labelling materials which stay intact under the harshest of conditions with the latest digital identification technology. Solutions it will showcase at Pharmapack include:

AD Minidose U9 – a small UHF inlay ideal for vial, tube, and syringe application identification 

AD TT Sensor Plus 2 – a small low-cost temperature data logger with NFC and Bluetooth capabilities 

AD Circus™ NFC - NFC inlay with product authentication capabilities

AD Circus™ Tamper Loop – a NFC inlay with tamper evidence capabilities to enable product authenticity

S2196 - a cold chain adhesive that is suitable for small diameter containers like prefilled syringes or vials and that will be stored in temperatures down to -196°C

AD Procerta - complimentary service designed specifically for brand owners to enable label material testing

Ewa Weglinska at Avery Dennison LPM, EMENA comments:

“The pharmaceutical sector is of vital importance to all of us and our solutions play a key role in helping to keep patients safe and ensure optimized packaging and labeling processes. RFID technology can bring endless benefits to pharma. Supply chain transparency and inventory management help with waste reduction whilst NFC helps greatly with brand protection and patient compliance. In combination with our label materials that are tested and proven to perform in typical pharma applications we are bringing unique solutions to the market. These are vital factors that enhance patient safety and we look forward to showcasing these technologies at Pharmapack.”
Pharmapack 2024

 

Media contact: 

David Bell 

lpm.eu.pr.inquiries@eu.averydennison.com


About Avery Dennison

Avery Dennison Corporation (NYSE: AVY) is a global materials science and digital identification solutions company that provides branding and information labeling solutions, including pressure-sensitive materials, radio-frequency identification (RFID) inlays and tags, and a variety of converted products and solutions. The company designs and manufactures a wide range of labeling and functional materials that enhance branded packaging, carry or display information that connects the physical and the digital, and improve customers’ product performance. The company serves an array of industries worldwide, including home and personal care, apparel, e-commerce, logistics, food and grocery, pharmaceuticals and automotive. The company employs approximately 36,000 employees in more than 50 countries. Reported sales in 2022 were $9.0 billion. Learn more at www.averydennison.com.